FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313483854> ?p ?o ?g. }

• W4313483854 abstract "Oxidative stress is an imbalance between reactive oxygen species production and elimination, favoring the former. Reactive oxygen species serve as important signaling molecules for physiological homeostasis. However, when produced in excess, these once important signaling molecules become detrimental, disrupting cellular functions, and ultimately leading to cell death. In aging, reactive oxygen species production is increased, accompanied with reductions in oxidative stress resistance, increasing the risk for developing age-related diseases including cardiovascular disease, cancer, stroke, and neurodegenerative diseases. The outer mitochondrial membrane iron-sulfur cluster containing protein mitoNEET (CISD1; gene CISD1) has shown to be a mediator of mitochondrial function and oxidative stress. Groups have developed in vitro and in vivo models to study the loss of mitoNEET on cellular and physiological functions associated with aging, but as the field of mitoNEET research is fairly new, there are many questions that have yet to be explored. This dissertation investigates the influence of mitoNEET expression on age-related oxidative stress resistance to environmental stressors and in an Alzheimer’s disease model via genetic manipulations and pharmacological tools. To understand the effects of mitoNEET on age-related oxidative stress resistance to environmental stressors, transgenic mitoNEET knockout and overexpression Caenorhabditis elegans models were generated, aged, and exposed to the pro-oxidant paraquat. Upon paraquat exposure, mitoNEET overexpression models showed a reduction in overall oxidative stress and reactive oxygen species formation, supported by increases in mitochondrial superoxide dismutase expression and activation of the p38 mitogen activated protein kinase (MAPK) signaling cascade. With this understanding of the mechanisms by which mitoNEET overexpression attenuates oxidative stress, the next steps taken were to understand if preservation of mitoNEET expression provides the same benefits in an Alzheimer’s disease model. Alzheimer’s disease is a progressive, neurodegenerative disease, and the most common form of dementia. It is estimated that 6 million people in the U.S. are living with Alzheimer’s disease, with this number to more than double by 2060. While there are FDA-approved drugs for Alzheimer’s disease, there is no cure, and these drugs only slow the symptoms of disease progression. Studies have shown that oxidative stress contributes to the pathogenesis and progression of Alzheimer’s disease. Furthermore, mitoNEET has not been studied in models of Alzheimer’s disease. Therefore, the second study in this dissertation aimed to evaluate mitoNEET as a potential drug target to mediate oxidative stress in an Alzheimer’s disease C. elegans model that expresses the A��42 pathology using the novel thiazolidinedione-class mitoNEET agonist CI987. Investigation of CI987 showed elevated mitoNEET expression in both young and aged populations of C. elegans models of Alzheimer’s disease. Furthermore, CI987 treated populations showed reductions in oxidative stress and reactive oxidative species production, in part due to elevations in mitochondrial superoxide dismutase expression. Future efforts should investigate the reproducibility of these results in rodent models of Alzheimer’s disease, further analyzing the mechanisms of CI987 treatment on mitoNEET expression, and mitochondrial bioenergetics and function. In summary, this dissertation establishes a new direction in the field of aging and Alzheimer’s disease research, with the hope of using mitoNEET as a new target for the development of new drugs to combat neurodegeneration." @default.
• W4313483854 created "2023-01-06" @default.
• W4313483854 creator A5004944786 @default.
• W4313483854 date "2023-01-04" @default.
• W4313483854 modified "2023-09-26" @default.
• W4313483854 title "Investigating the mitochondrial protein mitoNEET in C. elegans models of aging and Alzheimer's disease" @default.
• W4313483854 doi "https://doi.org/10.33915/etd.11453" @default.
• W4313483854 hasPublicationYear "2023" @default.
• W4313483854 type Work @default.
• W4313483854 citedByCount "0" @default.
• W4313483854 crossrefType "dissertation" @default.
• W4313483854 hasAuthorship W4313483854A5004944786 @default.
• W4313483854 hasConcept C185592680 @default.
• W4313483854 hasConcept C2776151105 @default.
• W4313483854 hasConcept C2776527163 @default.
• W4313483854 hasConcept C28859421 @default.
• W4313483854 hasConcept C48349386 @default.
• W4313483854 hasConcept C55493867 @default.
• W4313483854 hasConcept C86803240 @default.
• W4313483854 hasConcept C95444343 @default.
• W4313483854 hasConceptScore W4313483854C185592680 @default.
• W4313483854 hasConceptScore W4313483854C2776151105 @default.
• W4313483854 hasConceptScore W4313483854C2776527163 @default.
• W4313483854 hasConceptScore W4313483854C28859421 @default.
• W4313483854 hasConceptScore W4313483854C48349386 @default.
• W4313483854 hasConceptScore W4313483854C55493867 @default.
• W4313483854 hasConceptScore W4313483854C86803240 @default.
• W4313483854 hasConceptScore W4313483854C95444343 @default.
• W4313483854 hasLocation W43134838541 @default.
• W4313483854 hasOpenAccess W4313483854 @default.
• W4313483854 hasPrimaryLocation W43134838541 @default.
• W4313483854 hasRelatedWork W1528674127 @default.
• W4313483854 hasRelatedWork W167559315 @default.
• W4313483854 hasRelatedWork W2123946628 @default.
• W4313483854 hasRelatedWork W2149460060 @default.
• W4313483854 hasRelatedWork W2417394622 @default.
• W4313483854 hasRelatedWork W2529661909 @default.
• W4313483854 hasRelatedWork W2587676932 @default.
• W4313483854 hasRelatedWork W2995162523 @default.
• W4313483854 hasRelatedWork W3120339133 @default.
• W4313483854 hasRelatedWork W98214784 @default.
• W4313483854 isParatext "false" @default.
• W4313483854 isRetracted "false" @default.
• W4313483854 workType "dissertation" @default.